Asia Pacific Qpcr Instruments Market Size & Outlook
Asia Pacific qpcr instruments market, 2018-2030 (US$M)
Asia Pacific qpcr instruments market highlights
- The Asia Pacific qpcr instruments market generated a revenue of USD 214.0 million in 2023.
- The market is expected to grow at a CAGR of 8.9% from 2024 to 2030.
- In terms of segment, 7500 was the largest revenue generating test type in 2023.
- 7500 is the most lucrative test type segment registering the fastest growth during the forecast period.
Asia Pacific data book summary
| Market revenue in 2023 | USD 214.0 million |
| Market revenue in 2030 | USD 389.7 million |
| Growth rate | 8.9% (CAGR from 2023 to 2030) |
| Largest segment | 7500 |
| Fastest growing segment | 7500 |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | 7500 |
| Key market players worldwide | Thermo Fisher Scientific Inc, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Danaher Corp, Qiagen NV, Agilent Technologies Inc, Abbott Laboratories, BioMerieux SA, Azure Biosystems, Bio Molecular Systems |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 20.9% of the global qpcr instruments market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 389.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
QPCR Instruments Market Scope
QPCR Instruments Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific qpcr instruments market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to qpcr instruments market will help companies and investors design strategic landscapes.
7500 was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific qpcr instruments market based on 7500 covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is estimated to exhibit a lucrative CAGR of 15.7% over the forecast period. It is expected to be the fastest-growing region over the forecast period. Cell and gene therapies are becoming a common treatment for cancer.
They form 50% of the total therapies approved for cancer globally, making it crucial in driving the demand for qPCR instruments. Hence, growing incidence of cancer in the region can propel the demand for biologics as well as cell & gene therapies.
Investments in vaccine manufacturing facilities are anticipated to further propel the market. For instance, Such initiatives are expected to position Asian markets as strong contenders for growing demand of qPCR.
Reasons to subscribe to Asia Pacific qpcr instruments market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific qpcr instruments market databook
-
Our clientele includes a mix of qpcr instruments market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific qpcr instruments market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific qpcr instruments market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
